Please use this identifier to cite or link to this item:
|Title:||Management of chronic hepatitis B in challenging patient populations||Authors:||Dore, G.J.
Wasim Jafri, S.M.
Human immunodeficiency virus
|Issue Date:||Dec-2006||Citation:||Dore, G.J., Guan, R., Wasim Jafri, S.M., Sarin, S.V., Keeffe, E.B. (2006-12). Management of chronic hepatitis B in challenging patient populations. Liver International 26 (SUPPL. 2) : 38-46. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1478-3231.2006.01375.x||Abstract:||Clinicians face many challenges in striving to reduce the morbidity and mortality associated with chronic hepatitis B virus (HBV) infection. Some of the most urgent issues relate to preventing or reducing the development of antiviral resistance that may arise during oral antiviral therapy. In addition, the management of special populations, including patients with normal alanine aminotransferase levels, children and adolescents, women planning pregnancy or already pregnant, patients undergoing chemotherapy or other forms of immunosuppression, patients with HBV and human immunodeficiency virus coinfection, and those undergoing liver transplantation, present further challenges. This concise review examines recent findings on the efficacy of antiviral therapy in these special patient groups. © 2006 Blackwell Munksgaard.||Source Title:||Liver International||URI:||http://scholarbank.nus.edu.sg/handle/10635/133064||ISSN:||14783223||DOI:||10.1111/j.1478-3231.2006.01375.x|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 25, 2021
WEB OF SCIENCETM
checked on Feb 17, 2021
checked on Feb 13, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.